A sugar that’s been linked to cancer could also serve as an early indicator of severe scleroderma, improving diagnosis and treatment options for patients with this rare disease.
Catégorie : Network News
GlycoNet Investigator Dr. Matthew Macauley is uncovering how carbohydrates influence immune cells in the brain and their impact on Alzheimer’s disease.
GlycoNet is grateful to be one of the inaugural recipients of the Strategic Science Fund.
Travel Awards available for HQP(Trainees, Graduate Students, Postdoctoral Fellows & Research Associates)
GlycoNet Investigator’s discovery provides insight into a vital cellular process that could be leveraged to unlock new therapeutic pathways for neurodegenerative diseases and cancer.
Dr. Obadiah Plante, Dr. Antonia Borovina, Dr. Rika Jolie and Dr. Hamed Ghanei have joined the GlycoNet Board of Directors.
Tribute to Dr. G. Douglas Inglis by Dr. Wade Abbott.
The report encapsulates a comprehensive overview of the network’s achievements, breakthroughs, and collaborations in the field of glycomics throughout the past year.
Within the report, readers will gain insight into the cutting-edge research and advancements made by GlycoNet, a collaborative effort involving scientists, researchers, and experts from academia, industry, and government institutions. It delves into the pioneering discoveries in glycobiology, highlighting the innovative applications and technologies that have emerged within the network.
Senator Paula Simons recently toured GlycoNet at the University of Alberta, exploring the realm of glycomics. The visit highlighted GlycoNet’s pivotal role in advancing glycomics and its transformative impact across One Health domains, underlined by discussions with GlycoNet’s CEO, Dr. Elizabeth Nanak.
The tour of cutting-edge labs showcased passionate researchers driving innovation in glycomics, and interactions with start-ups like 48Hour Discovery shed light on drug discovery advancements. This visit emphasized the value of such engagements, illustrating the shared commitment to a thriving future and the potential for collaborative efforts to elevate healthcare and nurture a diverse bioeconomy.
New compounds could open more opportunities for vital medical treatments, organ and tissue transplants, and reproductive medicine.